Heat shock protein 90 (Hsp90) regulates the stability of transforming growth factor β-activated kinase 1 (TAK1) in interleukin-1β-induced cell signaling

被引:21
|
作者
Shi, Lijun [2 ]
Zhang, Zhengping [2 ]
Fang, Shuping [2 ]
Xu, Junfeng [2 ]
Liu, Junhong [2 ]
Shen, Jiayin [2 ]
Fang, Fang [2 ]
Luo, Lan [1 ]
Yin, Zhimin [2 ]
机构
[1] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China
[2] Nanjing Normal Univ, Coll Life Sci, Jiangsu Prov Key Lab Mol & Med Biotechnol, Nanjing 210046, Peoples R China
关键词
HsP90; TAK1; Geldanamycin; IL-1; beta; Inflammation; KAPPA-B ACTIVATION; N-TERMINAL DOMAIN; IN-VIVO FUNCTION; MOLECULAR CHAPERONE; TRANSDUCTION PATHWAY; ADAPTER PROTEIN; IL-1; RECEPTOR; COMPLEX; GELDANAMYCIN; IKK;
D O I
10.1016/j.molimm.2008.07.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heat shock protein 90 (Hsp90) is an abundantly and ubiquitously expressed chaperone with majority of client proteins which act as signal molecules. Transforming growth factor beta-activated kinase 1 (TAK1) is a mitogen-activated protein kinase kinase kinase (MAPKKK), and is essential in interleukin-1 beta (IL-1 beta) triggered signaling pathways. In the present study. we found that Hsp90 plays an important role in regulating IL-1 beta signaling by keeping TAK1 stability. The results showed that the specific inhibitor geldanamycin (GA) of Hsp90 dramatically inhibited IL-1 beta stimulated TAK1-MAPKs and TAK1-nuclear factor-kappa B (NF-kappa B) activation, resulting in the decrease of cyclooxygenase-2 (COX-2) protein expression. Silencing Hsp90 expression through RNA interference (RNAi) also down-regulated TAK1, as well as attenuated IL-1 beta induced phosphorylation of c-Jun NH2-terminal kinase (JNK) and p38 MAPKs, and degradation Of I kappa B alpha. The same results were obtained in T6RZC stable cells which initiated IL-1 beta-induced cell signaling at the level of the oligomerization and ubquitination of TNF receptor-associated factor 6 (TRAF6). We further found that Hsp90 formed a complex with TAK1 via its N-terminal domain and GA destabilized TAK1 and induced TAK1 degradation through proteasome pathway. Taken together our results demonstrate that Hsp90 regulates IL-1 beta-induced signaling by interacting with TAK1 and maintaining the stability of TAK1, suggesting that Hsp90 might act as the chaperone of TAK1 in immune and inflammatory responses related with IL-1 signal cascades. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:541 / 550
页数:10
相关论文
共 50 条
  • [31] TAK1 MAPK kinase kinase mediates transforming growth factor-β signaling by targeting SnoN oncoprotein for degradation
    Kajino, Taisuke
    Omori, Emily
    Ishii, Shunsuke
    Matsumoto, Kunihiro
    Ninomiya-Tsuji, Jun
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (13) : 9475 - 9481
  • [32] Tripartite Motif-Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor β-Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation
    Chen, San-Yang
    Zhang, Hua-Peng
    Li, Jie
    Shi, Ji-Hua
    Tang, Hong-Wei
    Zhang, Yi
    Zhang, Jia-Kai
    Wen, Pei-Hao
    Wang, Zhi-Hui
    Shi, Xiao-Yi
    He, Yu-Ting
    Hu, Bo-Wen
    Yang, Han
    Guo, Wen-Zhi
    Zhang, Shui-Jun
    HEPATOLOGY, 2021, 73 (02) : 738 - 758
  • [33] Transforming Growth Factor-β Activated Kinase 1 (Tak1) Is Activated in Hepatocellular Carcinoma, Mediates Tumor Progression, and Predicts Unfavorable Outcome
    Ridder, Dirk Andreas
    Urbansky, Lana Louisa
    Witzel, Hagen Roland
    Schindeldecker, Mario
    Weinmann, Arndt
    Berndt, Kristina
    Gerber, Tiemo Sven
    Koehler, Bruno Christian
    Nichetti, Federico
    Ludt, Annekathrin
    Gehrke, Nadine
    Schattenberg, Joern Markus
    Heinrich, Stefan
    Roth, Wilfried
    Straub, Beate Katharina
    CANCERS, 2022, 14 (02)
  • [34] Inhibiting Heat Shock Protein 90 (HSP90) Limits the Formation of Liver Cysts Induced by Conditional Deletion of Pkd1 in Mice
    Smithline, Zachary B.
    Nikonova, Anna S.
    Hensley, Harvey H.
    Cai, Kathy Q.
    Egleston, Brian L.
    Proia, David A.
    Seeger-Nukpezah, Tamina
    Golemis, Erica A.
    PLOS ONE, 2014, 9 (12):
  • [35] Multiple components of the HSP90 chaperone complex function in regulation of heat shock factor 1 in vivo
    Bharadwaj, S
    Ali, A
    Ovsenek, N
    MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (12) : 8033 - 8041
  • [36] Preclinical antitumor activity of SST0116CL1, a novel heat shock protein 90 (HSP90) inhibitor
    Vesci, Loredana
    Milazzo, Ferdinando
    Carollo, Valeria
    Pace, Silvia
    Giannini, Giuseppe
    CANCER RESEARCH, 2014, 74 (19)
  • [37] Correction to: Heat shock protein-90alpha (Hsp90α) stabilizes hypoxia-inducible factor-1α (HIF-1α) in support of spermatogenesis and tumorigenesis
    Xin Tang
    Cheng Chang
    Michelle Hao
    Mei Chen
    David T. Woodley
    Axel H. Schönthal
    Wei Li
    Cancer Gene Therapy, 2021, 28 : 1071 - 1072
  • [38] Inhibition of Transforming Growth Factor-Activated Kinase 1 (TAK1) Blocks and Reverses Epithelial to Mesenchymal Transition of Mesothelial Cells
    Strippoli, Raffaele
    Benedicto, Ignacio
    Perez Lozano, Maria Luisa
    Pellinen, Teijo
    Sandoval, Pilar
    Lopez-Cabrera, Manuel
    Angel del Pozo, Miguel
    PLOS ONE, 2012, 7 (02):
  • [39] Evidence of Co-purification of the Human T-cell Leukemia Virus Type 1 and Heat Shock Protein-90 (HSP90).
    Nwankwo, C.
    Gibson, T.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [40] ITZ-1, a Client-Selective Hsp90 Inhibitor, Efficiently Induces Heat Shock Factor 1 Activation
    Kimura, Haruhide
    Yukitake, Hiroshi
    Tajima, Yasukazu
    Suzuki, Hirobumi
    Chikatsu, Tomoko
    Morimoto, Shinji
    Funabashi, Yasunori
    Omae, Hiroaki
    Ito, Takashi
    Yoneda, Yukio
    Takizawa, Masayuki
    CHEMISTRY & BIOLOGY, 2010, 17 (01): : 18 - 27